Multiplex Assay Kit for Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay)

INSIGF; IGF-II; Somatomedin A; Preptin; Insulin-like growth factor II Ala-25 Del

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-89 85
EDTA plasma(n=5) 88-98 92
heparin plasma(n=5) 91-99 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 98-105% 90-103% 89-104% 80-97%
EDTA plasma(n=5) 84-91% 82-99% 91-99% 91-105%
heparin plasma(n=5) 87-101% 87-98% 80-101% 83-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:IGF2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
international Journal of food and nutritional sciences EVALUATION OF PHYSICO-CHEMICAL PROPERTIES OF COLOSTRUM SUPPLEMENTED DAHI Ijfans: Source
International Journal of Chemical Studies Studies on quality attributes of skimmed colostrum powder P-ISSN: 2349–8528
Neurobiology of Disease Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression Pubmed:29113829
Advanced Science IGFBP2 Plays an Essential Role in Cognitive Development during Early Life Pubmed: 31832311
PLoS One Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia Pubmed: 32191705
Current Medical Science Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics Pubmed: 32681260
ACS Omega Gastrodin Exerts Cardioprotective Action via Inhibition of Insulin-Like Growth Factor Type 2/Insulin-Like Growth Factor Type 2 Receptor Expression in Cardiac … 34250336
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA051Ra01 Recombinant Insulin Like Growth Factor 2 (IGF2) Positive Control; Immunogen; SDS-PAGE; WB.
APA051Ra01 Active Insulin Like Growth Factor 2 (IGF2) Cell culture; Activity Assays.
PAA051Ra01 Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2) WB; IHC; ICC; IP.
LAA051Ra81 FITC-Linked Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2) WB; IHC; ICC; IF.
LAA051Ra71 Biotin-Linked Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2) WB; IHC; ICC.
MAA051Ra21 Monoclonal Antibody to Insulin Like Growth Factor 2 (IGF2) WB; IHC; ICC; IP.
SEA051Ra ELISA Kit for Insulin Like Growth Factor 2 (IGF2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA051Ra Multiplex Assay Kit for Insulin Like Growth Factor 2 (IGF2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA051Ra01 ELISA Kit DIY Materials for Insulin Like Growth Factor 2 (IGF2) Main materials for "Do It(ELISA Kit) Yourself"